| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,211 |
2,139 |
$573K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,511 |
5,298 |
$545K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,871 |
938 |
$528K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,079 |
1,968 |
$507K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,217 |
3,233 |
$423K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,824 |
4,745 |
$371K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,189 |
689 |
$183K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
503 |
280 |
$124K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,857 |
1,228 |
$89K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,021 |
1,596 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,758 |
1,631 |
$46K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
644 |
539 |
$44K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,797 |
418 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,192 |
1,748 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,170 |
4,043 |
$26K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
278 |
233 |
$20K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,214 |
741 |
$18K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
133 |
54 |
$18K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
565 |
503 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,831 |
1,533 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,761 |
2,308 |
$15K |
| 80061 |
Lipid panel |
1,094 |
929 |
$14K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
219 |
154 |
$13K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
309 |
268 |
$11K |
| 82565 |
|
2,897 |
2,071 |
$11K |
| 70450 |
Computed tomography, head or brain; without contrast material |
85 |
38 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,472 |
955 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
451 |
370 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
691 |
590 |
$10K |
| 84460 |
|
3,449 |
2,427 |
$9K |
| 80051 |
|
1,089 |
809 |
$8K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
54 |
33 |
$7K |
| 90837 |
Psychotherapy, 53 minutes with patient |
87 |
65 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
298 |
196 |
$6K |
| 82040 |
|
2,022 |
1,350 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,057 |
723 |
$5K |
| 84075 |
|
2,220 |
1,497 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
253 |
210 |
$4K |
| 81001 |
|
1,966 |
1,389 |
$4K |
| 82247 |
|
2,278 |
1,528 |
$4K |
| 85610 |
|
1,136 |
556 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
365 |
154 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
54 |
36 |
$3K |
| 99215 |
Prolong outpt/office vis |
47 |
38 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
14 |
$3K |
| 0012A |
|
79 |
65 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
54 |
36 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
818 |
540 |
$2K |
| 84155 |
|
1,806 |
1,196 |
$2K |
| 0011A |
|
74 |
64 |
$2K |
| 99443 |
|
100 |
83 |
$2K |
| 84450 |
|
499 |
395 |
$2K |
| 82728 |
|
197 |
160 |
$2K |
| 83605 |
|
658 |
343 |
$2K |
| 87081 |
|
219 |
191 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,755 |
1,737 |
$2K |
| 82947 |
|
490 |
406 |
$2K |
| 83735 |
|
410 |
298 |
$1K |
| 90688 |
|
103 |
97 |
$1K |
| 84132 |
|
438 |
305 |
$1K |
| 87077 |
|
274 |
157 |
$1K |
| 84145 |
|
125 |
78 |
$1K |
| 86140 |
|
542 |
386 |
$1K |
| 80053 |
Comprehensive metabolic panel |
108 |
78 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
33 |
24 |
$847.20 |
| 82607 |
|
81 |
66 |
$835.68 |
| 99442 |
|
39 |
36 |
$664.08 |
| 87186 |
|
151 |
96 |
$589.01 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
18 |
12 |
$587.50 |
| 84484 |
|
233 |
97 |
$580.05 |
| 71045 |
Radiologic examination, chest; single view |
423 |
192 |
$531.87 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
53 |
25 |
$529.29 |
| 82310 |
|
139 |
95 |
$519.52 |
| 81003 |
|
365 |
284 |
$512.78 |
| 82043 |
|
69 |
51 |
$504.80 |
| 72100 |
|
19 |
12 |
$358.48 |
| 81025 |
|
50 |
43 |
$339.46 |
| 84520 |
|
146 |
103 |
$328.09 |
| 74019 |
|
34 |
25 |
$312.73 |
| 90658 |
|
18 |
13 |
$261.16 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
387 |
215 |
$241.34 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
349 |
228 |
$223.49 |
| 85027 |
|
48 |
39 |
$219.32 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
20 |
13 |
$166.10 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,441 |
1,237 |
$163.56 |
| 83690 |
|
30 |
27 |
$156.64 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
563 |
346 |
$148.50 |
| 82962 |
|
108 |
42 |
$141.16 |
| 84295 |
|
34 |
27 |
$122.22 |
| 83550 |
|
15 |
12 |
$90.30 |
| 87040 |
|
74 |
24 |
$76.01 |
| 83540 |
|
15 |
12 |
$66.90 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
426 |
205 |
$11.67 |
| A9270 |
Non-covered item or service |
3,783 |
572 |
$6.20 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
81 |
76 |
$3.20 |
| J7050 |
Infusion, normal saline solution, 250 cc |
543 |
221 |
$1.42 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
218 |
146 |
$1.19 |
| J3490 |
Unclassified drugs |
16 |
13 |
$0.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
179 |
98 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
47 |
24 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
194 |
125 |
$0.00 |